Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02361346
Title Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (MT-3724NHL001)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Molecular Templates, Inc.
Indications

chronic lymphocytic leukemia

diffuse large B-cell lymphoma

non-Hodgkin lymphoma

Therapies

MT-3724

Age Groups: adult | senior
Covered Countries USA | ESP | CAN


No variant requirements are available.